Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | LIPE | Q05469 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15908148 | 0.90 | ALDH1A1 (0.53) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL20792927 | 0.90 | ALDH1A1 (0.53) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL31575357 | 0.87 | ALDH1A1 (0.50) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL26419107 | 0.82 | MEN1 (0.56) | MEN1KMT2ANPSR1TRPV4ALDH1A1 | |
| SCHEMBL23277780 | 0.82 | ALDH1A1 (0.43) | MEN1KMT2ANPSR1TRPV4ALDH1A1 | |
| SCHEMBL22059743 | 0.82 | ALDH1A1 (0.49) | MEN1KMT2ANPSR1ALDH1A1MAPT | |
| SCHEMBL26327468 | 0.82 | ALDH1A1 (0.45) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15105924 | 0.81 | CHRM3 (0.46) | MEN1KMT2ANPSR1ALDH1A1 | |
| SCHEMBL23277976 | 0.80 | SIGMAR1 (0.46) | MEN1KMT2ANPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL20066468 | 0.78 | ALDH1A1 (0.56) | MEN1KMT2ANPSR1TRPV4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | PORCN, ORC3, COASY | MEN1 936/4885KMT2A 1660/4885NPSR1 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.